©Reuters.
INDIANAPOLIS – Elevance Health, Inc. (NYSE: ELV), formerly known as Anthem, Inc., has completed its acquisition of Paragon Healthcare, a Texas-based infusion services provider, the company announced today. The move is expected to strengthen Elevance Health's multi-site infusion and specialty pharmacy capabilities.
Paragon Healthcare specializes in providing IV and injectable treatments, serving more than 35,000 patients through more than 40 outpatient infusion centers and home infusion pharmacies across eight states. The acquisition is intended to further strengthen Elevance Health's commitment to providing access to specialty medicines for individuals with chronic and complex conditions.
According to Pete Heitaian, executive vice president of Elevance Health and president of Carelon, the medical services division that includes the pharmacy services division CarelonRx, the Paragon Healthcare combination will increase patient People will now have more flexibility in how they receive their medications. Mr. Haitian emphasized that this strategic move aims to “remove barriers to care, increase medication adherence, reduce costs of care, and better support the overall health of our members.”
Elevance Health plans to expand Paragon Healthcare's geographic reach and enhance treatment services to ensure members have timely and convenient access to medicines. Financial terms of the acquisition were not disclosed in the statement.
Elevance Health serves more than 115 million people and offers a broad portfolio of medical, digital, pharmacy, behavioral, clinical and complex care solutions. The company's purpose is to improve human health by supporting consumers, families and communities throughout the journey of care.
The acquisition is part of Elevance Health's broader strategy to provide integrated healthcare services and follows the trend of consolidation in the healthcare industry, where companies seek more comprehensive service offerings.
Information in this article is based on a press release from Elevance Health, Inc.
This article was generated with the help of AI and reviewed by an editor. Please see our Terms of Use for more information.
